McKesson (MCK) Given a $186.00 Price Target at Mizuho

McKesson (NYSE:MCK) has been assigned a $186.00 target price by analysts at Mizuho in a research note issued to investors on Wednesday. The brokerage presently has a “hold” rating on the stock. Mizuho’s price target indicates a potential upside of 6.54% from the stock’s previous close.

A number of other equities research analysts have also weighed in on the company. Needham & Company LLC set a $178.00 target price on McKesson and gave the company a “buy” rating in a research report on Tuesday, October 24th. Credit Suisse Group reiterated an “underperform” rating and issued a $130.00 price target (down from $155.00) on shares of McKesson in a report on Thursday, November 9th. Deutsche Bank assumed coverage on McKesson in a report on Monday, December 4th. They issued a “buy” rating and a $175.00 price target on the stock. Royal Bank of Canada reiterated a “hold” rating and issued a $170.00 price target on shares of McKesson in a report on Friday, October 27th. Finally, Zacks Investment Research upgraded McKesson from a “hold” rating to a “buy” rating and set a $177.00 price target on the stock in a report on Tuesday, December 26th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and eleven have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $178.68.

Shares of McKesson (NYSE:MCK) traded up $3.98 during midday trading on Wednesday, reaching $174.58. The company’s stock had a trading volume of 1,940,000 shares, compared to its average volume of 1,600,000. The company has a current ratio of 1.05, a quick ratio of 0.61 and a debt-to-equity ratio of 0.66. The company has a market cap of $36,400.00, a price-to-earnings ratio of 8.27, a PEG ratio of 1.76 and a beta of 1.23. McKesson has a 1-year low of $133.82 and a 1-year high of $177.97.

McKesson (NYSE:MCK) last issued its earnings results on Thursday, October 26th. The company reported $3.28 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.78 by $0.50. The business had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.69 billion. McKesson had a return on equity of 24.87% and a net margin of 2.24%. McKesson’s revenue was up 4.2% on a year-over-year basis. During the same period in the previous year, the company posted $2.94 EPS. equities research analysts anticipate that McKesson will post 12.26 earnings per share for the current year.

In related news, Chairman John H. Hammergren sold 65,000 shares of the business’s stock in a transaction on Thursday, December 14th. The stock was sold at an average price of $160.00, for a total transaction of $10,400,000.00. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.20% of the stock is owned by insiders.

Hedge funds have recently made changes to their positions in the stock. Ingalls & Snyder LLC grew its stake in McKesson by 76.7% during the 3rd quarter. Ingalls & Snyder LLC now owns 16,939 shares of the company’s stock worth $2,602,000 after buying an additional 7,352 shares during the last quarter. Whittier Trust Co. grew its stake in McKesson by 1.5% during the 3rd quarter. Whittier Trust Co. now owns 62,812 shares of the company’s stock worth $9,649,000 after buying an additional 898 shares during the last quarter. River & Mercantile Asset Management LLP grew its stake in McKesson by 278.6% during the 3rd quarter. River & Mercantile Asset Management LLP now owns 177,824 shares of the company’s stock worth $27,321,000 after buying an additional 130,852 shares during the last quarter. Synovus Financial Corp grew its stake in McKesson by 62.8% during the 3rd quarter. Synovus Financial Corp now owns 5,803 shares of the company’s stock worth $890,000 after buying an additional 2,238 shares during the last quarter. Finally, Cypress Capital Management LLC grew its stake in McKesson by 77.4% during the 2nd quarter. Cypress Capital Management LLC now owns 3,861 shares of the company’s stock worth $635,000 after buying an additional 1,684 shares during the last quarter. Hedge funds and other institutional investors own 87.84% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was first reported by American Banking and Market News and is the property of of American Banking and Market News. If you are viewing this story on another domain, it was illegally copied and reposted in violation of US and international trademark and copyright legislation. The correct version of this story can be accessed at https://www.americanbankingnews.com/2018/01/24/mckesson-mck-given-a-186-00-price-target-at-mizuho.html.

McKesson Company Profile

McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.